Mein Warenkorb

ADC lsotype Control Human IgG1 (MMAF) (MALS verified)

User Reviews
Product Number/Spec
Price
Menge
DNP-C904P1-100ug
$195.00
DNP-C904P1-1mg (500ug X 2)
$790.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Source

    Human IgG1 Kappa Isotype Control (mAb) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

  • Antibody Type

    Recombinant Monoclonal

  • Isotype

    Human IgG1, Kappa

  • Host Species

    Human

  • Conjugate

    MMAF

  • DAR

    4

  • Purification

    Protein A purified / Protein G purified.

  • Aggregation

    Less than 10%, as determined by SEC-MALS.

  • Concentration

    Please refer to the Certificate of Analysis (CoA).

  • Form

    Lyophilized

  • Formulation

    Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Reconstitution

    Please refer to the Certificate of Analysis (CoA) for specific instructions.

  • Shipping

    Lyophilized product is shipped at ambient temperature.

  • Storage

    For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

User Reviews
Publish Comment

Background Introduction

MMAF (Monomethyl auristatin F) is an auristatin-derived microtubule inhibitor. With a mechanism of action similar to MMAE, it inhibits tumor cell proliferation by interfering with microtubule dynamics, yet exhibits superior water solubility and plasma stability with lower off-target toxicity. As a cytotoxic payload for ADCs, it is suitable for developing anti-tumor ADCs for MMAE-resistant cases or those requiring reduced systemic toxicity.

Frontier Progress

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • User Reviews
  • Hintergrund
Kontaktieren Sie uns